Polarized light therapy: Shining a light on the mechanism underlying its immunomodulatory effects

J Biophotonics. 2020 Mar;13(3):e201960177. doi: 10.1002/jbio.201960177. Epub 2019 Dec 29.

Abstract

This study investigates the immunomodulatory effects of polychromatic polarized light therapy (PLT) on human monocyte cells. While there is some evidence demonstrating a clinical effect in the treatment of certain conditions, there is little research into its mechanism of action. Herein, U937 monocyte cells were cultured and exposed to PLT. The cells were then analyzed for change in expression of genes and cell surface markers relating to inflammation. It was noted that 6 hours of PLT reduced the expression of the CD14, MHC I and CD11b receptors, and increased the expression of CD86. It was also shown that PLT caused downregulation of the genes IL1B, CCL2, NLRP3 and NOD1, and upregulation of NFKBIA and TLR9. These findings imply that PLT has the capacity for immunomodulation in human immune cells, possibly exerting an anti-inflammatory effect.

Keywords: inflammation; phototherapy; polarized light; polarized light therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunomodulation*
  • Inflammation
  • Monocytes
  • Phototherapy*
  • U937 Cells